MetaADEDB 2.0 @ LMMD
Amlodipine
(ZPBWCRDSRKPIDG-UHFFFAOYSA-N)
Structure
SMILES
OS(=O)(=O)c1ccccc1.NCCOCC1=C(C(=O)OCC)C(C(=C(N1)C)C(=O)OC)c1ccccc1Cl
Molecular Formula:
C26H31ClN2O8S
Molecular Weight:
567.051
Log P:
5.3095
Hydrogen Bond Acceptor:
10
Hydrogen Bond Donor:
3
TPSA:
162.63
CAS Number(s):
111470-99-6
Synonym(s)
1.
Amlodipine
2.
Amlodipine Besylate
3.
Amlodipine Maleate
4.
Amlodipine Maleate (1:1)
5.
Amlodipine, (+-)-Isomer
6.
Amlodipine, (+-)-Isomer, Maleate (1:1)
7.
Amlodipine, (R)-Isomer
8.
Amlodipine, (S)-Isomer, Maleate (1:1)
9.
Amlodis
10.
Amlor
11.
Astudal
12.
Istin
13.
Norvasc
External Link(s)
MeSHD017311
PubChem Compound60496
11330522
ChEBI2669
CHEMBLCHEMBL3207778
CHEMBL3193637
CHEMBL1200402
KEGGdr:D00615
Therapeutic Target DatabaseD0H7WA
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 233
Canada Vigilance: 13
Canada Vigilance
US FAERS
2DizzinessFAERS: 172
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
3HypotensionFAERS: 162US FAERS
4HeadacheFAERS: 140
Canada Vigilance: 2
Canada Vigilance
US FAERS
5Toxicity to various agentsFAERS: 109US FAERS
6Completed SuicideFAERS: 103US FAERS
7OverdoseFAERS: 98US FAERS
8MalaiseFAERS: 96
Canada Vigilance: 2
Canada Vigilance
US FAERS
9NauseaFAERS: 95OFFSIDES
US FAERS
10Peripheral swellingFAERS: 94
Canada Vigilance: 1
Canada Vigilance
US FAERS
11Blood pressure inadequately controlledFAERS: 88
Canada Vigilance: 2
Canada Vigilance
US FAERS
12Joint swellingFAERS: 81
Canada Vigilance: 2
Canada Vigilance
US FAERS
13SwellingFAERS: 80US FAERS
14FatigueFAERS: 77
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
15Feeling abnormalFAERS: 70US FAERS
16PalpitationsFAERS: 67US FAERS
17PruritusFAERS: 63US FAERS
18Product substitution issueFAERS: 54US FAERS
19Suicide attemptFAERS: 48US FAERS
20AstheniaFAERS: 43
Canada Vigilance: 1
Canada Vigilance
US FAERS
21ShockFAERS: 43US FAERS
22PainFAERS: 42OFFSIDES
US FAERS
23VomitingFAERS: 42
Canada Vigilance: 4
Canada Vigilance
US FAERS
24Chest PainFAERS: 38
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
25SomnolenceFAERS: 38US FAERS
26Throat irritationFAERS: 38
Canada Vigilance: 1
Canada Vigilance
US FAERS
27UrticariaFAERS: 37US FAERS
28Metabolic acidosisFAERS: 36US FAERS
29HypersensitivityFAERS: 33
Canada Vigilance: 2
Canada Vigilance
US FAERS
30LethargyFAERS: 32US FAERS
31Abdominal discomfortFAERS: 30US FAERS
32ArthralgiaFAERS: 30US FAERS
33TremorFAERS: 30
Canada Vigilance: 2
Canada Vigilance
US FAERS
34Cardiac ArrestFAERS: 29US FAERS
35MyalgiaFAERS: 29US FAERS
36FlushingFAERS: 28US FAERS
37Product solubility abnormalFAERS: 28US FAERS
38Gingival HyperplasiaFAERS: 26US FAERS
39ErythemaFAERS: 25OFFSIDES
US FAERS
40Abdominal PainFAERS: 24OFFSIDES
US FAERS
41BradycardiaFAERS: 24US FAERS
42TachycardiaFAERS: 24US FAERS
43AnxietyFAERS: 23OFFSIDES
US FAERS
44Product quality issueFAERS: 23US FAERS
45Sinus TachycardiaFAERS: 23US FAERS
46ChokingFAERS: 20US FAERS
47Blood pressure fluctuationFAERS: 19US FAERS
48Burning sensationFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
49ConstipationFAERS: 19US FAERS
50SyncopeFAERS: 19
Canada Vigilance: 2
Canada Vigilance
US FAERS
51Acute kidney injuryFAERS: 18US FAERS
52AlopeciaFAERS: 18US FAERS
53Visual ImpairmentFAERS: 18US FAERS
54Chest discomfortFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
55Erectile dysfunctionFAERS: 16OFFSIDES
US FAERS
56TinnitusFAERS: 16US FAERS
57AngioedemaFAERS: 15US FAERS
58Drug level increasedFAERS: 15US FAERS
59HypoxiaFAERS: 15OFFSIDES
US FAERS
60NervousnessFAERS: 15US FAERS
61DysgeusiaFAERS: 14US FAERS
62Oropharyngeal painFAERS: 14US FAERS
63Cerebrovascular accidentFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
64DiscomfortFAERS: 13US FAERS
65Product taste abnormalFAERS: 13US FAERS
66Respiratory FailureFAERS: 13OFFSIDES
US FAERS
67Diabetes MellitusFAERS: 12US FAERS
68Drug effect incompleteFAERS: 12US FAERS
69InflammationFAERS: 12US FAERS
70Activities of daily living impairedFAERS: 11US FAERS
71Back PainFAERS: 11US FAERS
72DisorientationFAERS: 11US FAERS
73DyspepsiaFAERS: 11US FAERS
74PurpuraFAERS: 11US FAERS
75Sinus bradycardiaFAERS: 11OFFSIDES
US FAERS
76Accidental overdoseFAERS: 10US FAERS
77AcidosisFAERS: 10US FAERS
78AnuriaFAERS: 10US FAERS
79AscitesFAERS: 10US FAERS
80GingivitisFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
81Intentional product misuseFAERS: 10US FAERS
82Lip swellingFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
83Mental impairmentFAERS: 10US FAERS
84OliguriaFAERS: 10OFFSIDES
US FAERS
85Product physical issueFAERS: 10US FAERS
86Angina PectorisFAERS: 9US FAERS
87Blood glucose increasedFAERS: 9US FAERS
88Depressed Level of ConsciousnessFAERS: 9US FAERS
89Exposure via breast milkFAERS: 9US FAERS
90Head discomfortFAERS: 9US FAERS
91Pharmaceutical product complaintFAERS: 9US FAERS
92AgitationFAERS: 8US FAERS
93Blood creatinine increasedFAERS: 8US FAERS
94DysphoniaFAERS: 8US FAERS
95Feeling ColdFAERS: 8US FAERS
96Maternal exposure during breast feedingFAERS: 8US FAERS
97Memory impairmentFAERS: 8US FAERS
98Neck PainFAERS: 8US FAERS
99Product use issueFAERS: 8US FAERS
100Reaction to drug excipientsFAERS: 8US FAERS
101Atrial FibrillationFAERS: 7US FAERS
102DehydrationFAERS: 7OFFSIDES
US FAERS
103DysarthriaFAERS: 7US FAERS
104Loss of personal independence in daily activitiesFAERS: 7US FAERS
105Musculoskeletal stiffnessFAERS: 7US FAERS
106NocturiaFAERS: 7US FAERS
107PresyncopeFAERS: 7US FAERS
108RhabdomyolysisFAERS: 7OFFSIDES
US FAERS
109Therapeutic response unexpected with drug substitutionFAERS: 7US FAERS
110Unresponsive to stimuliFAERS: 7US FAERS
111VertigoFAERS: 7US FAERS
112WheezingFAERS: 7US FAERS
113Adverse eventFAERS: 6US FAERS
114AngerFAERS: 6US FAERS
115Blood potassium decreasedFAERS: 6US FAERS
116Blood urine presentFAERS: 6US FAERS
117Cold sweatFAERS: 6US FAERS
118Coma scale abnormalFAERS: 6US FAERS
119Distributive shockFAERS: 6US FAERS
120Drug ineffective for unapproved indicationFAERS: 6US FAERS
121Ear discomfortFAERS: 6US FAERS
122EczemaFAERS: 6OFFSIDES
US FAERS
123NephrolithiasisFAERS: 6OFFSIDES
US FAERS
124Product size issueFAERS: 6US FAERS
125Product use complaintFAERS: 6US FAERS
126Skin UlcerFAERS: 6US FAERS
127ThirstFAERS: 6US FAERS
128Urinary RetentionFAERS: 6US FAERS
129Wrong technique in product usage processFAERS: 6US FAERS
130AbasiaFAERS: 5OFFSIDES
US FAERS
131Accidental exposure to product by childFAERS: 5US FAERS
132AmnesiaFAERS: 5OFFSIDES
US FAERS
133Blood creatine phosphokinase increasedFAERS: 5OFFSIDES
US FAERS
134Cardiac dysfunctionFAERS: 5US FAERS
135Depressed moodFAERS: 5US FAERS
136Drug dispensing errorFAERS: 5US FAERS
137Drug exposure during pregnancyFAERS: 5US FAERS
138Dry skinFAERS: 5OFFSIDES
US FAERS
139DysuriaFAERS: 5US FAERS
140EpistaxisFAERS: 5OFFSIDES
US FAERS
141Foreign body in respiratory tractFAERS: 5US FAERS
142Hypertensive crisisFAERS: 5US FAERS
143Incorrect dose administeredFAERS: 5US FAERS
144Lichen PlanusFAERS: 5US FAERS
145Musculoskeletal PainFAERS: 5US FAERS
146Myocardial InfarctionFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
147Night sweatsFAERS: 5US FAERS
148No adverse eventFAERS: 5US FAERS
149PolyuriaFAERS: 5US FAERS
150Product coating issueFAERS: 5US FAERS
151Respiratory arrestFAERS: 5US FAERS
152Respiratory distressFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
153Weight decreasedFAERS: 5US FAERS
154Acute respiratory failureFAERS: 4US FAERS
155Alanine Aminotransferase IncreasedFAERS: 4OFFSIDES
US FAERS
156Altered state of consciousnessFAERS: 4US FAERS
157Anaphylactic shockFAERS: 4US FAERS
158ArthritisFAERS: 4OFFSIDES
US FAERS
159BlindnessFAERS: 4US FAERS
160Drug level above therapeuticFAERS: 4US FAERS
161DystoniaFAERS: 4US FAERS
162EructationFAERS: 4US FAERS
163Extra dose administeredFAERS: 4US FAERS
164Eye painFAERS: 4US FAERS
165Feeling jitteryFAERS: 4US FAERS
166FlatulenceFAERS: 4OFFSIDES
US FAERS
167Gingival HypertrophyFAERS: 4US FAERS
168LeukocytosisFAERS: 4US FAERS
169Limb discomfortFAERS: 4OFFSIDES
US FAERS
170OsteoporosisFAERS: 4OFFSIDES
US FAERS
171PemphigusFAERS: 4US FAERS
172Personality ChangeFAERS: 4US FAERS
173Product shape issueFAERS: 4US FAERS
174Product use in unapproved indicationFAERS: 4US FAERS
175ProteinuriaFAERS: 4US FAERS
176SepsisFAERS: 4US FAERS
177SneezingFAERS: 4US FAERS
178Stevens-Johnson SyndromeFAERS: 4US FAERS
179StressFAERS: 4US FAERS
180Troponin increasedFAERS: 4US FAERS
181Unevaluable eventFAERS: 4US FAERS
182Urine ketone body presentFAERS: 4US FAERS
183Vitreous floatersFAERS: 4US FAERS
184AgranulocytosisFAERS: 3US FAERS
185Aspartate Aminotransferase IncreasedFAERS: 3US FAERS
186Atrioventricular BlockFAERS: 3US FAERS
187BlepharospasmFAERS: 3US FAERS
188Blood pH decreasedFAERS: 3US FAERS
189Cardiac FlutterFAERS: 3US FAERS
190CellulitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
191Choking sensationFAERS: 3OFFSIDES
US FAERS
192DissociationFAERS: 3US FAERS
193Drug prescribing errorFAERS: 3US FAERS
194Drug toxicityFAERS: 3US FAERS
195Emotional disorderFAERS: 3US FAERS
196FormicationFAERS: 3US FAERS
197GastritisFAERS: 3US FAERS
198Joint injuryFAERS: 3US FAERS
199Leukocytoclastic vasculitisFAERS: 3US FAERS
200Limb injuryFAERS: 3US FAERS
201Lower respiratory tract infectionFAERS: 3US FAERS
202Maternal exposure during pregnancyFAERS: 3US FAERS
203Mental status changesFAERS: 3OFFSIDES
US FAERS
204Muscle tightnessFAERS: 3US FAERS
205Musculoskeletal discomfortFAERS: 3OFFSIDES
US FAERS
206Noninfective gingivitisFAERS: 3US FAERS
207PallorFAERS: 3US FAERS
208Pancreatic carcinomaFAERS: 3US FAERS
209Pericardial effusionFAERS: 3OFFSIDES
US FAERS
210PoisoningFAERS: 3US FAERS
211PseudolymphomaFAERS: 3US FAERS
212PsoriasisFAERS: 3US FAERS
213Tablet physical issueFAERS: 3US FAERS
214Tooth LossFAERS: 3US FAERS
215Toxic Epidermal NecrolysisFAERS: 3US FAERS
216Urinary IncontinenceFAERS: 3US FAERS
217jaundiceFAERS: 3US FAERS
218Abnormal weight gainFAERS: 2US FAERS
219AcneFAERS: 2US FAERS
220AkathisiaFAERS: 2US FAERS
221Allergic reaction to excipientFAERS: 2US FAERS
222Apallic syndromeFAERS: 2US FAERS
223ApathyFAERS: 2US FAERS
224AphoniaFAERS: 2OFFSIDES
US FAERS
225ArteriosclerosisFAERS: 2OFFSIDES
US FAERS
226Blood aldosterone decreasedFAERS: 2US FAERS
227Blood creatine increasedFAERS: 2US FAERS
228Blood parathyroid hormone increasedFAERS: 2US FAERS
229Blood sodium decreasedFAERS: 2US FAERS
230Blood urea increasedFAERS: 2US FAERS
231BronchitisFAERS: 2OFFSIDES
US FAERS
232CapillaritisFAERS: 2US FAERS
233Capillary Leak SyndromeFAERS: 2US FAERS
234CardiomegalyFAERS: 2US FAERS
235CholelithiasisFAERS: 2US FAERS
236CholestasisFAERS: 2US FAERS
237Cholestatic liver injuryFAERS: 2US FAERS
238ChromaturiaFAERS: 2US FAERS
239Circumstance or information capable of leading to medication errorFAERS: 2US FAERS
240Coronary Artery DiseaseFAERS: 2US FAERS
241Disseminated intravascular coagulation in newbornFAERS: 2US FAERS
242DiverticulitisFAERS: 2US FAERS
243Drug administration errorFAERS: 2US FAERS
244Drug dose omissionFAERS: 2US FAERS
245Drug level decreasedFAERS: 2US FAERS
246Duodenogastric RefluxFAERS: 2US FAERS
247DyscheziaFAERS: 2US FAERS
248EcchymosisFAERS: 2US FAERS
249Economic problemFAERS: 2US FAERS
250ExophthalmosFAERS: 2US FAERS
251Eye InfectionFAERS: 2US FAERS
252Feeling of body temperature changeFAERS: 2US FAERS
253Food AllergyFAERS: 2OFFSIDES
US FAERS
254HemiplegiaFAERS: 2US FAERS
255HepatitisFAERS: 2US FAERS
256HypokinesiaFAERS: 2US FAERS
257HypoperfusionFAERS: 2US FAERS
258ImpatienceFAERS: 2US FAERS
259InfectionFAERS: 2OFFSIDES
US FAERS
260Intentional drug misuseFAERS: 2US FAERS
261Intentional self-injuryFAERS: 2OFFSIDES
US FAERS
262Intestinal ObstructionFAERS: 2US FAERS
263Loose toothFAERS: 2US FAERS
264LymphadenopathyFAERS: 2US FAERS
265Medication ErrorFAERS: 2US FAERS
266Morbid thoughtsFAERS: 2OFFSIDES
US FAERS
267Mouth swellingFAERS: 2US FAERS
268Multiple allergiesFAERS: 2US FAERS
269Muscle strainFAERS: 2US FAERS
270PancytopeniaFAERS: 2US FAERS
271ParanoiaFAERS: 2US FAERS
272Pelvic PainFAERS: 2US FAERS
273PeriodontitisFAERS: 2US FAERS
274Peritoneal effluent leukocyte count increasedFAERS: 2US FAERS
275PetechiaeFAERS: 2US FAERS
276PolyhydramniosFAERS: 2US FAERS
277Product complaintFAERS: 2US FAERS
278Product formulation issueFAERS: 2US FAERS
279Productive CoughFAERS: 2US FAERS
280Psychiatric symptomFAERS: 2US FAERS
281Pulmonary congestionFAERS: 2US FAERS
282RalesFAERS: 2US FAERS
283Rash erythematousFAERS: 2US FAERS
284Reaction to excipientFAERS: 2US FAERS
285Rectal spasmFAERS: 2US FAERS
286Renal painFAERS: 2US FAERS
287Renin decreasedFAERS: 2US FAERS
288Renin increasedFAERS: 2US FAERS
289RestlessnessFAERS: 2US FAERS
290RetchingFAERS: 2US FAERS
291RhonchiFAERS: 2US FAERS
292RosaceaFAERS: 2US FAERS
293ScabFAERS: 2OFFSIDES
US FAERS
294Sexual DysfunctionFAERS: 2US FAERS
295Skin reactionFAERS: 2US FAERS
296StomatitisFAERS: 2US FAERS
297ToothacheFAERS: 2US FAERS
298TorticollisFAERS: 2US FAERS
299Traumatic Brain InjuryFAERS: 2US FAERS
300Traumatic liver injuryFAERS: 2US FAERS
301Urethral StenosisFAERS: 2US FAERS
302Vascular resistance systemic decreasedFAERS: 2US FAERS
303Vulvovaginal burning sensationFAERS: 2US FAERS
304White blood cell count decreasedFAERS: 2US FAERS
305Wrong drug administeredFAERS: 2US FAERS
306Abnormal sleep-related eventFAERS: 1US FAERS
307Accidental exposure to productFAERS: 1US FAERS
308Accidental exposureFAERS: 1US FAERS
309Acute Lung InjuryFAERS: 1US FAERS
310Acute cutaneous lupus erythematosusFAERS: 1US FAERS
311Alcohol interactionFAERS: 1US FAERS
312Ankle FractureFAERS: 1US FAERS
313Ankylosing spondylitisFAERS: 1US FAERS
314AphagiaFAERS: 1OFFSIDES
US FAERS
315Aphthous StomatitisFAERS: 1US FAERS
316Apparent deathFAERS: 1US FAERS
317Arterial thrombosisFAERS: 1US FAERS
318ArthropathyFAERS: 1US FAERS
319AsthmaFAERS: 1US FAERS
320AtelectasisFAERS: 1US FAERS
321Base excess decreasedFAERS: 1US FAERS
322BedriddenFAERS: 1OFFSIDES
US FAERS
323Bladder painFAERS: 1US FAERS
324Bleeding time shortenedFAERS: 1US FAERS
325Blood blisterFAERS: 1US FAERS
326Blood cholesterol increasedFAERS: 1US FAERS
327Blood creatine phosphokinase MB increasedFAERS: 1US FAERS
328Blood creatinine decreasedFAERS: 1US FAERS
329Blood glucose abnormalFAERS: 1US FAERS
330Blood magnesium decreasedFAERS: 1US FAERS
331Blood testosterone increasedFAERS: 1US FAERS
332Blood triglycerides increasedFAERS: 1US FAERS
333Bone painFAERS: 1US FAERS
334Brain DeathFAERS: 1US FAERS
335Brain stem syndromeFAERS: 1US FAERS
336Bronchial HyperreactivityFAERS: 1US FAERS
337BruxismFAERS: 1US FAERS
338Carcinoembryonic antigen increasedFAERS: 1US FAERS
339CarcinogenicityFAERS: 1US FAERS
340Cerebellar infarctionFAERS: 1US FAERS
341Cerebral InfarctionFAERS: 1US FAERS
342Cerebral disorderFAERS: 1US FAERS
343Cerebral hypoperfusionFAERS: 1US FAERS
344ChillsFAERS: 1US FAERS
345Chronic gastritisFAERS: 1US FAERS
346Chronic pigmented purpuraFAERS: 1US FAERS
347Coagulation time shortenedFAERS: 1US FAERS
348Congenital cystic kidney diseaseFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
349Contact lens intoleranceFAERS: 1US FAERS
350Creatinine renal clearance decreasedFAERS: 1OFFSIDES
US FAERS
351CystFAERS: 1US FAERS
352Cytolytic hepatitisFAERS: 1US FAERS
353Cytomegalovirus enterocolitisFAERS: 1US FAERS
354DeafnessFAERS: 1US FAERS
355DeliriumFAERS: 1US FAERS
356DementiaFAERS: 1US FAERS
357DemyelinationFAERS: 1OFFSIDES
US FAERS
358Diabetes mellitus inadequate controlFAERS: 1OFFSIDES
US FAERS
359DiplopiaFAERS: 1US FAERS
360Disease recurrenceFAERS: 1US FAERS
361Drug screen false positiveFAERS: 1US FAERS
362DysplasiaFAERS: 1US FAERS
363Ear congestionFAERS: 1US FAERS
364Ejection Fraction DecreasedFAERS: 1US FAERS
365Electrocardiogram abnormalFAERS: 1US FAERS
366Emotional distressFAERS: 1US FAERS
367Endoscopy upper gastrointestinal tract abnormalFAERS: 1US FAERS
368Enzyme abnormalityFAERS: 1US FAERS
369Eosinophilic PneumoniaFAERS: 1US FAERS
370Essential HypertensionFAERS: 1US FAERS
371Expired product administeredFAERS: 1US FAERS
372Eye irritationFAERS: 1US FAERS
373Eyelids pruritusFAERS: 1US FAERS
374Facial NeuralgiaFAERS: 1US FAERS
375Flat affectFAERS: 1US FAERS
376Fluid overloadFAERS: 1OFFSIDES
US FAERS
377Gait inabilityFAERS: 1US FAERS
378Gastric FistulaFAERS: 1US FAERS
379Gastric ulcer helicobacterFAERS: 1US FAERS
380Gastric ulcerFAERS: 1OFFSIDES
US FAERS
381Gastrointestinal hypomotilityFAERS: 1US FAERS
382Gastrointestinal motility disorderFAERS: 1OFFSIDES
US FAERS
383General physical condition abnormalFAERS: 1US FAERS
384General physical health deteriorationFAERS: 1US FAERS
385Gingival AtrophyFAERS: 1US FAERS
386Gingival RecessionFAERS: 1US FAERS
387Gingival erythemaFAERS: 1US FAERS
388GoutFAERS: 1US FAERS
389HepatomegalyFAERS: 1US FAERS
390HepatotoxicityFAERS: 1US FAERS
391HerniaFAERS: 1US FAERS
392HordeolumFAERS: 1US FAERS
393HostilityFAERS: 1US FAERS
394HungerFAERS: 1US FAERS
395Hyperdynamic left ventricleFAERS: 1US FAERS
396HypersomniaFAERS: 1US FAERS
397HypohidrosisFAERS: 1US FAERS
398HypothyroidismFAERS: 1US FAERS
399Idiopathic angioedemaFAERS: 1US FAERS
400Idiopathic urticariaFAERS: 1US FAERS
401Impaired driving abilityFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
402Inappropriate schedule of drug administrationFAERS: 1US FAERS
403Incision site abscessFAERS: 1US FAERS
404Increased upper airway secretionFAERS: 1US FAERS
405Initial insomniaFAERS: 1US FAERS
406Intentional product use issueFAERS: 1US FAERS
407Joint stiffnessFAERS: 1OFFSIDES
US FAERS
408Labile blood pressureFAERS: 1OFFSIDES
US FAERS
409LeukopeniaFAERS: 1US FAERS
410Libido disorderFAERS: 1US FAERS
411Live BirthFAERS: 1US FAERS
412Low birth weight babyFAERS: 1US FAERS
413Low density lipoprotein increasedFAERS: 1US FAERS
414Lyme DiseaseFAERS: 1US FAERS
415LymphomaFAERS: 1US FAERS
416Macular degenerationFAERS: 1US FAERS
417Malignant HypertensionFAERS: 1US FAERS
418Micturition frequency decreasedFAERS: 1US FAERS
419Middle insomniaFAERS: 1US FAERS
420MoaningFAERS: 1US FAERS
421Mouth BreathingFAERS: 1US FAERS
422Multiple drug overdose intentionalFAERS: 1US FAERS
423Muscle hypertrophyFAERS: 1US FAERS
424Musculoskeletal chest painFAERS: 1US FAERS
425MyopiaFAERS: 1OFFSIDES
US FAERS
426NasopharyngitisFAERS: 1US FAERS
427NecrosisFAERS: 1US FAERS
428NephrectomyFAERS: 1US FAERS
429NephrosclerosisFAERS: 1US FAERS
430Nerve injuryFAERS: 1US FAERS
431NeuritisFAERS: 1US FAERS
432OnychoclasisFAERS: 1US FAERS
433Oral candidiasisFAERS: 1US FAERS
434Oral mucosal hypertrophyFAERS: 1OFFSIDES
US FAERS
435Oral painFAERS: 1US FAERS
436Oropharyngeal blisteringFAERS: 1US FAERS
437Oropharyngeal discomfortFAERS: 1US FAERS
438PCO2 decreasedFAERS: 1US FAERS
439PO2 increasedFAERS: 1US FAERS
440Pain of skinFAERS: 1US FAERS
441ParotitisFAERS: 1US FAERS
442Pharmaceutical product counterfeitFAERS: 1US FAERS
443PhlebitisFAERS: 1US FAERS
444PhotophobiaFAERS: 1US FAERS
445Pneumatosis intestinalisFAERS: 1US FAERS
446PneumoniaFAERS: 1US FAERS
447Polymyalgia RheumaticaFAERS: 1US FAERS
448PolyneuropathyFAERS: 1US FAERS
449Poor quality drug administeredFAERS: 1US FAERS
450Portal Vein ThrombosisFAERS: 1US FAERS
451Product counterfeitFAERS: 1US FAERS
452Product dispensing errorFAERS: 1US FAERS
453Product dose omissionFAERS: 1US FAERS
454Product friableFAERS: 1US FAERS
455Product label issueFAERS: 1US FAERS
456Product name confusionFAERS: 1US FAERS
457Product residue presentFAERS: 1US FAERS
458Prostate cancer recurrentFAERS: 1US FAERS
459Pseudobulbar PalsyFAERS: 1US FAERS
460Pulmonary EmbolismFAERS: 1US FAERS
461Pyogenic granulomaFAERS: 1US FAERS
462Quality of life decreasedFAERS: 1OFFSIDES
US FAERS
463Recalled product administeredFAERS: 1US FAERS
464Reflux gastritisFAERS: 1US FAERS
465Refusal of treatment by relativeFAERS: 1US FAERS
466Renal cystFAERS: 1US FAERS
467Respiratory DepressionFAERS: 1US FAERS
468Respiratory tract congestionFAERS: 1US FAERS
469Retinal DetachmentFAERS: 1US FAERS
470SciaticaFAERS: 1US FAERS
471Secretion dischargeFAERS: 1US FAERS
472Sinus headacheFAERS: 1US FAERS
473Sinus painFAERS: 1US FAERS
474Skin ErosionFAERS: 1US FAERS
475Skin hypertrophyFAERS: 1OFFSIDES
US FAERS
476Skin irritationFAERS: 1US FAERS
477Skin lesionFAERS: 1OFFSIDES
US FAERS
478Slow response to stimuliFAERS: 1US FAERS
479SunburnFAERS: 1US FAERS
480Suspected counterfeit productFAERS: 1US FAERS
481Tablet issueFAERS: 1US FAERS
482Therapeutic product effect incompleteFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
483Therapeutic response unexpectedFAERS: 1US FAERS
484Thermal burnFAERS: 1US FAERS
485ThrombocytopeniaFAERS: 1US FAERS
486ThrombosisFAERS: 1US FAERS
487Tinea crurisFAERS: 1US FAERS
488Tongue discomfortFAERS: 1US FAERS
489Toxicologic test abnormalFAERS: 1US FAERS
490Trigeminal NeuralgiaFAERS: 1US FAERS
491Umbilical herniaFAERS: 1US FAERS
492Upper respiratory tract irritationFAERS: 1US FAERS
493Upper-airway cough syndromeFAERS: 1US FAERS
494Urge IncontinenceFAERS: 1US FAERS
495Vaginal DischargeFAERS: 1US FAERS
496Vasodilation procedureFAERS: 1US FAERS
497Ventricular hypokinesiaFAERS: 1US FAERS
498Vulvovaginal swellingFAERS: 1US FAERS
499Waist circumference increasedFAERS: 1US FAERS
500Withdrawal hypertensionFAERS: 1US FAERS
501Wrong patient received medicationFAERS: 1US FAERS
502Wrong technique in drug usage processFAERS: 1US FAERS
503furuncleFAERS: 1US FAERS
504muscle injuryFAERS: 1US FAERS
505nervous system disorderFAERS: 1US FAERS
506Abnormal visionOFFSIDES
507AdenomaOFFSIDES
508AlveolitisOFFSIDES
509AnorexiaOFFSIDES
510AspergillosisOFFSIDES
511Bile duct cancer stage IIIOFFSIDES
512Biliary dilatationOFFSIDES
513Blood GlucoseOFFSIDES
514Blood albumin decreasedOFFSIDES
515Blood cholesterolOFFSIDES
516Blood glucose decreasedOFFSIDES
517Blood immunoglobulin A decreasedOFFSIDES
518Blood sodium abnormalOFFSIDES
519Blood sodiumOFFSIDES
520Blood urea abnormalOFFSIDES
521Blood uric acidOFFSIDES
522Blurred visionOFFSIDES
523Brain natriuretic peptide decreasedOFFSIDES
524Brain scan abnormalOFFSIDES
525Bronchoalveolar LavageOFFSIDES
526Cardiac asthmaOFFSIDES
527Cerebral atrophyOFFSIDES
528CholangiolitisOFFSIDES
529Choroidal DetachmentOFFSIDES
530Chronic Fatigue SyndromeOFFSIDES
531Chronic Obstructive Airway DiseaseOFFSIDES
532ClumsinessOFFSIDES
533Compression fractureOFFSIDES
534ConfabulationOFFSIDES
535Congenital tricuspid valve incompetenceOFFSIDES
536Dental prosthesis placementOFFSIDES
537DiabetesOFFSIDES
538Diabetic NephropathyOFFSIDES
539DiarrheaOFFSIDES
540Diastolic dysfunctionOFFSIDES
541Differential white blood cell count abnormalOFFSIDES
542Diffuse Large B-Cell LymphomaOFFSIDES
543EctropionOFFSIDES
544Ejection fraction abnormalOFFSIDES
545EndocarditisOFFSIDES
546Endodontic procedureOFFSIDES
547Endothelin abnormalOFFSIDES
548Erosive gastritisOFFSIDES
549Esophageal StenosisOFFSIDES
550ExcoriationOFFSIDES
551Femoral artery occlusionOFFSIDES
552FilariasisOFFSIDES
553Gamma-Glutamyltransferase IncreasedOFFSIDES
554Gastric DilatationOFFSIDES
555GastrinomaOFFSIDES
556GlaucomaOFFSIDES
557GranulocytosisOFFSIDES
558HemiparesisOFFSIDES
559Hepatic vein stenosisOFFSIDES
560Hip surgeryOFFSIDES
561HyperkeratosisOFFSIDES
562HyperpigmentationOFFSIDES
563Immunosuppressant drug level decreasedOFFSIDES
564Impaired gastric emptyingOFFSIDES
565Infusion site mobility decreasedOFFSIDES
566Interleukin-2 receptor increasedOFFSIDES
567Joint InstabilityOFFSIDES
568Joint Range of Motion DecreasedOFFSIDES
569Joint warmthOFFSIDES
570Keratitis siccaOFFSIDES
571Kidney FailureOFFSIDES
572Lactose IntoleranceOFFSIDES
573LeishmaniasisOFFSIDES
574Lung infection pseudomonalOFFSIDES
575Malignant neoplasm progressionOFFSIDES
576Mallory-Weiss SyndromeOFFSIDES
577MeningiomaOFFSIDES
578Muscle WeaknessOFFSIDES
579Mycosis FungoidesOFFSIDES
580Myoglobin blood increasedOFFSIDES
581Nephrogenic Fibrosing DermopathyOFFSIDES
582Open reduction of fractureOFFSIDES
583Open woundOFFSIDES
584Oral infectionOFFSIDES
585OsteomyelitisOFFSIDES
586OsteopeniaOFFSIDES
587Panel-reactive antibody increasedOFFSIDES
588Peripheral arterial occlusive diseaseOFFSIDES
589Pharyngeal swellingCanada Vigilance: 1Canada Vigilance
590Pharyngolaryngeal PainOFFSIDES
591Post procedural cellulitisOFFSIDES
592Postoperative feverOFFSIDES
593Prolapse repairOFFSIDES
594Psychotic disorder due to a general medical conditionOFFSIDES
595Pulmonary HypertensionOFFSIDES
596Pulmonary thrombosisOFFSIDES
597Rectal ProlapseOFFSIDES
598Renal artery occlusionOFFSIDES
599Renal tubular necrosisOFFSIDES
600Retinal Artery OcclusionOFFSIDES
601RhinorrheaOFFSIDES
602SarcoidosisOFFSIDES
603SchizophreniaOFFSIDES
604SclerodermaOFFSIDES
605ScotomaOFFSIDES
606Septic ShockOFFSIDES
607Shoulder PainOFFSIDES
608Skin IndurationOFFSIDES
609Skin neoplasm excisionOFFSIDES
610Skin tightnessOFFSIDES
611Subcutaneous noduleOFFSIDES
612TendinitisOFFSIDES
613Therapeutic product effect decreasedCanada Vigilance: 1Canada Vigilance
614Transfusion ReactionOFFSIDES
615Upper respiratory tract inflammationOFFSIDES
616Ureterostomy site discomfortOFFSIDES
617Vitreous DetachmentOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.